Terms: = Breast cancer AND SMAD4, JIP, Q13485, 4089, ENSG00000141646, MADH4, DPC4 AND Prognosis
22 results:
1. Loss of tumor-derived smad4 enhances primary tumor growth but not metastasis following BMP4 signalling.
Chi LH; Redfern AD; Roslan S; Street IP; Burrows AD; Anderson RL
Cell Commun Signal; 2024 Apr; 22(1):248. PubMed ID: 38689334
[TBL] [Abstract] [Full Text] [Related]
2. The targeted next-generation sequence revealed smad4, AKT1, and TP53 mutations from circulating cell-free DNA of breast cancer and its effect on protein structure - A computational approach.
Balasundaram A; Kumar S U; D TK; Anil Dedge A; R G; K SS; R S; C GPD
J Biomol Struct Dyn; 2023; 41(24):15584-15597. PubMed ID: 37011004
[TBL] [Abstract] [Full Text] [Related]
3. Cyclin-dependent kinase subunit2 (CKS2) promotes malignant phenotypes and epithelial-mesenchymal transition-like process in glioma by activating TGFβ/SMAD signaling.
Feng F; Zhao Z; Cai X; Heng X; Ma X
Cancer Med; 2023 Mar; 12(5):5889-5907. PubMed ID: 36284444
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of biomarkers, genetic mutations, and epigenetic modifications in early diagnosis of pancreatic cancer.
Rah B; Banday MA; Bhat GR; Shah OJ; Jeelani H; Kawoosa F; Yousuf T; Afroze D
World J Gastroenterol; 2021 Sep; 27(36):6093-6109. PubMed ID: 34629822
[TBL] [Abstract] [Full Text] [Related]
5. The novel driver gene ASAP2 is a potential druggable target in pancreatic cancer.
Fujii A; Masuda T; Iwata M; Tobo T; Wakiyama H; Koike K; Kosai K; Nakano T; Kuramitsu S; Kitagawa A; Sato K; Kouyama Y; Shimizu D; Matsumoto Y; Utsunomiya T; Ohtsuka T; Yamanishi Y; Nakamura M; Mimori K
Cancer Sci; 2021 Apr; 112(4):1655-1668. PubMed ID: 33605496
[TBL] [Abstract] [Full Text] [Related]
6. TGFβ regulates NK1R-Tr to affect the proliferation and apoptosis of breast cancer cells.
Wang L; Wang N; Zhang R; Dong D; Liu R; Zhang L; Ji W; Yu M; Zhang F; Niu R; Zhou Y
Life Sci; 2020 Sep; 256():117674. PubMed ID: 32380077
[TBL] [Abstract] [Full Text] [Related]
7. Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers.
Hancock BA; Chen YH; Solzak JP; Ahmad MN; Wedge DC; Brinza D; Scafe C; Veitch J; Gottimukkala R; Short W; Atale RV; Ivan M; Badve SS; Schneider BP; Lu X; Miller KD; Radovich M
Breast Cancer Res; 2019 Aug; 21(1):87. PubMed ID: 31383035
[TBL] [Abstract] [Full Text] [Related]
8. smad4 alteration associates with invasive-front pathological markers and poor prognosis in colorectal cancer.
Oyanagi H; Shimada Y; Nagahashi M; Ichikawa H; Tajima Y; Abe K; Nakano M; Kameyama H; Takii Y; Kawasaki T; Homma KI; Ling Y; Okuda S; Takabe K; Wakai T
Histopathology; 2019 May; 74(6):873-882. PubMed ID: 30636020
[TBL] [Abstract] [Full Text] [Related]
9. Mutations in BRCA1, BRCA2, and PALB2, and a panel of 50 cancer-associated genes in pancreatic ductal adenocarcinoma.
Takeuchi S; Doi M; Ikari N; Yamamoto M; Furukawa T
Sci Rep; 2018 May; 8(1):8105. PubMed ID: 29802286
[TBL] [Abstract] [Full Text] [Related]
10. MicroRNA-574 enhances doxorubicin resistance through down-regulating smad4 in breast cancer cells.
Sun FD; Wang PC; Luan RL; Zou SH; Du X
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1342-1350. PubMed ID: 29565492
[TBL] [Abstract] [Full Text] [Related]
11. Expression Pattern of smad4/GATA3 as a Predictor of Survival in Invasive Ductal Carcinoma of the breast.
Min KW; Kim DH; Do SI; Chae SW; Kim K; Sohn JH; Lee HJ; Do IG; Pyo JS; Kim Y; Kim DH; Yang JH; Lee SJ; Oh YH; Oh S; Choi SH; Park YL; Park CH; Kim EK; Kwon MJ; Seo J
Pathobiology; 2017; 84(3):130-138. PubMed ID: 28288473
[TBL] [Abstract] [Full Text] [Related]
12. Comprehensive profiling of metaplastic breast carcinomas reveals frequent overexpression of programmed death-ligand 1.
Joneja U; Vranic S; Swensen J; Feldman R; Chen W; Kimbrough J; Xiao N; Reddy S; Palazzo J; Gatalica Z
J Clin Pathol; 2017 Mar; 70(3):255-259. PubMed ID: 27531819
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic factors in the myoepithelial-like spindle cell type of metaplastic breast cancer.
Leo F; Bartels S; Mägel L; Framke T; Büsche G; Jonigk D; Christgen M; Lehmann U; Kreipe H
Virchows Arch; 2016 Aug; 469(2):191-201. PubMed ID: 27220763
[TBL] [Abstract] [Full Text] [Related]
14. TIF1γ interferes with TGFβ1/smad4 signaling to promote poor outcome in operable breast cancer patients.
Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R
BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677
[TBL] [Abstract] [Full Text] [Related]
15. TGFβ-induced invasion of prostate cancer cells is promoted by c-Jun-dependent transcriptional activation of Snail1.
Thakur N; Gudey SK; Marcusson A; Fu JY; Bergh A; Heldin CH; Landström M
Cell Cycle; 2014; 13(15):2400-14. PubMed ID: 25483191
[TBL] [Abstract] [Full Text] [Related]
16. smad4 is a potential prognostic marker in human breast carcinomas.
Liu NN; Xi Y; Callaghan MU; Fribley A; Moore-Smith L; Zimmerman JW; Pasche B; Zeng Q; Li YL
Tumour Biol; 2014 Jan; 35(1):641-50. PubMed ID: 23975369
[TBL] [Abstract] [Full Text] [Related]
17. The prognostic role of TGF-β signaling pathway in breast cancer patients.
de Kruijf EM; Dekker TJA; Hawinkels LJAC; Putter H; Smit VTHBM; Kroep JR; Kuppen PJK; van de Velde CJH; Ten Dijke P; Tollenaar RAEM; Mesker WE
Ann Oncol; 2013 Feb; 24(2):384-390. PubMed ID: 23022998
[TBL] [Abstract] [Full Text] [Related]
18. Spheroid assay to measure TGF-β-induced invasion.
Naber HP; Wiercinska E; Ten Dijke P; van Laar T
J Vis Exp; 2011 Nov; (57):. PubMed ID: 22126971
[TBL] [Abstract] [Full Text] [Related]
19. The smad4 protein and prognosis of pancreatic ductal adenocarcinoma.
Tascilar M; Skinner HG; Rosty C; Sohn T; Wilentz RE; Offerhaus GJ; Adsay V; Abrams RA; Cameron JL; Kern SE; Yeo CJ; Hruban RH; Goggins M
Clin Cancer Res; 2001 Dec; 7(12):4115-21. PubMed ID: 11751510
[TBL] [Abstract] [Full Text] [Related]
20. Association of poor prognosis with loss of 12q, 17p, and 18q, and concordant loss of 6q/17p and 12q/18q in human pancreatic ductal adenocarcinoma.
Yatsuoka T; Sunamura M; Furukawa T; Fukushige S; Yokoyama T; Inoue H; Shibuya K; Takeda K; Matsuno S; Horii A
Am J Gastroenterol; 2000 Aug; 95(8):2080-5. PubMed ID: 10950061
[TBL] [Abstract] [Full Text] [Related]
[Next]
